The goal of the LiveLikeLou Center for ALS Research is to develop new treatments and, ultimately, a cure for amyotrophic lateral sclerosis (ALS) and to improve the quality of life for people who are now living with the progressive, degenerative neurological condition.
More information about the research being conducted by the LiveLikeLou Center’s scientific director, Christopher Donnelly, PhD, is available at www.donnellylab.com.
Philanthropic giving plays a significant role in helping our scientists discover the basic science causes of ALS and other neurodegenerative diseases.
The LiveLikeLou Center for ALS Research does not provide health care. For information on treatment available through the University of Pittsburgh and UPMC, we refer you to the MDA-ALS Center.